Successful use of rivaroxaban in inferior vena cava thrombosis provoked by multiple traumatic injuries and surgeries: A case report. (11th May 2017)

• Record Type: Journal Article
• Authors: Kido, K.; Noyes, E.; Gutnik, L.
• Is Part Of: Journal of clinical pharmacy and therapeutics. Volume 42:Number 5(2017)
• Page Start: 631
• Page End: 633
• Publication Date: 2017-05-11
• Subjects: anticoagulation -- antithrombotic therapy -- inferior vena cava thrombosis -- rivaroxaban; Clinical pharmacology -- Periodicals; Chemotherapy -- Periodicals; 615
• DOI: 10.1111/jcpt.12552
• Languages: English
• ISSNs: 0269-4727

Abstract

Summary: What is known and objectives: There is a lack of consensus regarding optimal anticoagulation regimen and duration for inferior vena cava (IVC) thrombus due to the paucity of clinical evidence. A case of IVC thrombus treated with 3 months of rivaroxaban therapy is reported. Case description: Fifty‐two‐year‐old male Caucasian presented following a motorcycle accident, with multiple left rib fractures requiring emergent amputation surgeries. During the hospitalization, he developed IVC thrombosis and completed 3 months of rivaroxaban treatment without any complication. The Doppler images at 6‐week, 3‐month and 6‐month follow‐up appointments showed no IVC thrombosis. What is new and conclusion: This is the first case of IVC thrombosis successfully treated with rivaroxaban. Further case series and clinical studies are needed to guide the use of direct oral anticoagulants for IVC thrombosis. Abstract : There is a lack of consensus regarding the optimal anticoagulation for inferior vena cava (IVC) thrombosis. This is the first reported case of IVC thrombosis successfully treated with rivaroxaban. Rivaroxaban is an appropriate alternative for IVC thrombosis.